Neuberger Berman Group
MLAB icon

Neuberger Berman Group’s Mesa Laboratories MLAB Stock Holding History

Neuberger Berman Group’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,564
Closed -$201K – 1853
2023
Q2 		$201K Sell
1,564
-1
-0.1% -$152 ﹤0.01% 1707
2023
Q1 		$273K Sell
1,565
-128
-8% -$22.9K ﹤0.01% 1629
2022
Q4 		$281K Sell
1,693
-77
-4% -$12.1K ﹤0.01% 1611
2022
Q3 		$249K Sell
1,770
-71
-4% -$13K ﹤0.01% 1667
2022
Q2 		$376K Sell
1,841
-178
-9% -$39K ﹤0.01% 1568
2022
Q1 		$514K Sell
2,019
-121
-6% -$32.9K ﹤0.01% 1536
2021
Q4 		$701K Sell
2,140
-3
-0.1% -$942 ﹤0.01% 1453
2021
Q3 		$647K Buy
2,143
+379
+21% +$108K ﹤0.01% 1414
2021
Q2 		$479K Buy
1,764
+76
+5% +$19.3K ﹤0.01% 1489
2021
Q1 		$411K Hold
1,688
– – ﹤0.01% 1527
2020
Q4 		$484K Sell
1,688
-12,892
-88% -$3.55M ﹤0.01% 1397
2020
Q3 		$3.71M Buy
14,580
+1,291
+10% +$307K ﹤0.01% 919
2020
Q2 		$2.88M Buy
13,289
+1,519
+13% +$350K ﹤0.01% 936
2020
Q1 		$2.66M Buy
11,770
+4,899
+71% +$1.21M ﹤0.01% 881
2019
Q4 		$1.71M Sell
6,871
-52
-0.8% -$12.2K ﹤0.01% 1060
2019
Q3 		$1.65M Buy
6,923
+4,863
+236% +$1.12M ﹤0.01% 1054
2019
Q2 		$503K Buy
2,060
+3
+0.1% +$699 ﹤0.01% 1294
2019
Q1 		$474K Sell
2,057
-220
-10% -$49.7K ﹤0.01% 1268
2018
Q4 		$475K Sell
2,277
-90
-4% -$17.6K ﹤0.01% 1273
2018
Q3 		$439K Sell
2,367
-211
-8% -$42.5K ﹤0.01% 1339
2018
Q2 		$544K Sell
2,578
-18
-0.7% -$3.15K ﹤0.01% 1381
2018
Q1 		$385K Sell
2,596
-6
-0.2% -$818 ﹤0.01% 1407
2017
Q4 		$323K Buy
2,602
+29
+1% +$4.06K ﹤0.01% 1521
2017
Q3 		$384K Buy
2,573
+20
+0.8% +$2.82K ﹤0.01% 1361
2017
Q2 		$366K Sell
2,553
-111
-4% -$15.8K ﹤0.01% 1371
2017
Q1 		$327K Buy
2,664
+261
+11% +$32K ﹤0.01% 1401
2016
Q4 		$295K Buy
2,403
+406
+20% +$50.7K ﹤0.01% 1419
2016
Q3 		$228K Buy
1,997
+316
+19% +$36K ﹤0.01% 1479
2016
Q2 		$207K Buy
+1,681
New +$181K ﹤0.01% 1459
2014
Q2 		– Sell
-14,329
Closed -$1.29M – 1739
2014
Q1 		$1.29M Buy
+14,329
New +$1.22M ﹤0.01% 1172

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Neuberger Berman Group's MLAB Position: Q3 2023 in Review

Neuberger Berman Group sold out of Mesa Laboratories (MLAB) in Q3 2023, closing a stake of 1,564 shares — an estimated $201K sold.

Neuberger Berman Group first reported a position in MLAB in Q1 2014 and held it in 30 quarters. The position peaked at $3.71M in Q3 2020. 154 funds tracked by Wall St. Rank hold MLAB as of Q3 2023.

  • Neuberger Berman Group reported no remaining Mesa Laboratories position as of Q3 2023 after selling out during the quarter.
  • Neuberger Berman Group sold 1,564 Mesa Laboratories shares in Q3 2023, an estimated $201K.
  • Neuberger Berman Group first reported a position in Mesa Laboratories in Q1 2014 and held it in 30 quarters.
  • Neuberger Berman Group's Mesa Laboratories position peaked at $3.71M in Q3 2020.
  • 154 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2023.

Based on Neuberger Berman Group's 13F filing for Q3 2023, filed 14 Nov 2023.